
|Videos|May 7, 2021
Focusing on 24-month data of the PALADIN study
Author(s)OTE Staff Reports, David Hutton
Dr Michael A. Singer speaks on the highlights of his presentation focusing on IOP in the PALADIN 24-month data intravitreal steroid (ILUVIEN).
Advertisement
Dr Michael A. Singer of the Medical Center Ophthalmology Associates in San Antonio, Texas, speaks on the highlights of his presentation focusing on intraocular pressure (IOP) in the PALADIN 24-month data intravitreal steroid (ILUVIEN), presented during ARVO 2021.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Ophthalmic care uncommon after tamoxifen initiation
2
Training refractive surgeons and expanding access to eye surgery
3
Empire Forum 2026: Ambati on K8 phase 2 results in geographic atrophy
4
Looking beyond visual acuity in macular telangiectasia
5















